awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34441748-C72F6120-4859-48DA-A5AE-0064A14F5C0D
Q34441748-C72F6120-4859-48DA-A5AE-0064A14F5C0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34441748-C72F6120-4859-48DA-A5AE-0064A14F5C0D
Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma.
P2860
Q34441748-C72F6120-4859-48DA-A5AE-0064A14F5C0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34441748-C72F6120-4859-48DA-A5AE-0064A14F5C0D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da27f95576b523c471c2ae6f286155b283e94d05
P2860
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells